These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7417923

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of thioridazine on the intellectual performance of mentally retarded drug responders and nonresponders.
    Breuning SE, Ferguson DG, Davidson NA, Poling AD.
    Arch Gen Psychiatry; 1983 Mar; 40(3):309-13. PubMed ID: 6338856
    [Abstract] [Full Text] [Related]

  • 3. Gas-liquid chromatographic method for the measurement of plasma levels of d-7,8-dimethoxy-3-methyl-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine acid maleate (SCH-12679) and its major metabolites in aggressive mental retardites.
    Cooper SF, Elie R, Albert JM, Gravel GB, Langlois Y.
    J Chromatogr; 1979 May 01; 163(1):47-56. PubMed ID: 528626
    [Abstract] [Full Text] [Related]

  • 4. Treatment of human aggression with major tranquilizers, antidepressants, and newer psychotropic drugs.
    Itil TM, Wadud A.
    J Nerv Ment Dis; 1975 Feb 01; 160(2-1):83-99. PubMed ID: 235010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Experience with Risperidone in the treatment of institutionalized mentally retarded patients, with special reference to treatment of aggressive states].
    Hal V, Fehér L.
    Neuropsychopharmacol Hung; 2004 Mar 01; 6(1):19-25. PubMed ID: 15125310
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic children.
    Saletu B, Saletu M, Simeon J, Viamontes G, Itil TM.
    Biol Psychiatry; 1975 Jun 01; 10(3):253-75. PubMed ID: 1095081
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A clinical evaluation of mesoridazine in mentally retarded patients.
    Zaleski W.
    Can Psychiatr Assoc J; 1970 Jun 01; 15(3):319-22. PubMed ID: 4913609
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
    Breuning SE, Davis VJ, Matson JL, Ferguson DG.
    Am J Psychiatry; 1982 Nov 01; 139(11):1447-54. PubMed ID: 6753612
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical behavioral pharmacology: methods for evaluating medications and contingency management.
    Burgio LD, Page TJ, Capriotti RM.
    J Appl Behav Anal; 1985 Nov 01; 18(1):45-59. PubMed ID: 3997697
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study.
    Amore M, Bertelli M, Villani D, Tamborini S, Rossi M.
    J Intellect Disabil Res; 2011 Feb 01; 55(2):210-8. PubMed ID: 21129058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.